Thomas Borén
Corporate Officer/Principal chez Umea Universitet
Profil
Thomas Borén was the founder of Helicure AB, which he founded in 2005 and served as Chief Scientific Officer until 2011.
Currently, he holds the title of Professor at Umea Universitet.
Postes actifs de Thomas Borén
| Sociétés | Poste | Début |
|---|---|---|
| Umea Universitet | Corporate Officer/Principal | - |
Anciens postes connus de Thomas Borén
| Sociétés | Poste | Fin |
|---|---|---|
Helicure AB
 Helicure AB Pharmaceuticals: MajorHealth Technology Helicure AB develops and manufactures vaccines. It operates as a biotech company that focuses on developing vaccines for prevention of gastric cancer caused by Helicobacter pylori, through active immunisation in infected patients with persistent dyspepsia. The company was founded by Thomas Borén and Lennart Hammarström in 2005 and is headquartered in Umea, Sweden. | Directeur Général | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Helicure AB
Helicure AB Pharmaceuticals: MajorHealth Technology Helicure AB develops and manufactures vaccines. It operates as a biotech company that focuses on developing vaccines for prevention of gastric cancer caused by Helicobacter pylori, through active immunisation in infected patients with persistent dyspepsia. The company was founded by Thomas Borén and Lennart Hammarström in 2005 and is headquartered in Umea, Sweden. | Health Technology |
